Literature DB >> 26143384

Short-Term Treprostinil Use in Infants with Congenital Diaphragmatic Hernia following Repair.

Emma Olson1, Leslie A Lusk2, Jeffrey R Fineman1, Laura Robertson3, Roberta L Keller4.   

Abstract

We describe 2 infants with congenital diaphragmatic hernia with severe pulmonary hypertension at 6 weeks. Treprostinil was used with rapid clinical improvement. Repeat cardiac catheterization showed dramatic improvement. Both infants were weaned off the drug, representing the first reports of successful short-term treprostinil use in neonates with congenital diaphragmatic hernia. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26143384      PMCID： PMC4554975          DOI： 10.1016/j.jpeds.2015.06.016

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  7 in total

1.  Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; W E Truog; W F Walsh; R N Goldberg; E Bancalari; D E Mayock; G J Redding; R A deLemos; S Sardesai; D C McCurnin; S G Moreland; G R Cutter; S H Abman
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

2.  Persistence of pulmonary hypertension by echocardiography predicts short-term outcomes in congenital diaphragmatic hernia.

Authors:  Leslie A Lusk; Katherine C Wai; Anita J Moon-Grady; Martina A Steurer; Roberta L Keller
Journal:  J Pediatr       Date:  2014-11-18       Impact factor: 4.406

3.  Incidence, predictors and outcomes of congenital diaphragmatic hernia: a population-based study of 32 million births in the United States.

Authors:  Jacques Balayla; Haim A Abenhaim
Journal:  J Matern Fetal Neonatal Med       Date:  2013-11-29

4.  Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy.

Authors:  Roberta L Keller; Phillip Moore; David Teitel; Samuel Hawgood; John McQuitty; Jeffrey R Fineman
Journal:  Pediatr Crit Care Med       Date:  2006-11       Impact factor: 3.624

5.  Outcomes of congenital diaphragmatic hernia in the modern era of management.

Authors:  Julia Wynn; Usha Krishnan; Gudrun Aspelund; Yuan Zhang; Jimmy Duong; Charles J H Stolar; Eunice Hahn; John Pietsch; Dai Chung; Donald Moore; Eric Austin; George Mychaliska; Robert Gajarski; Yen-Lim Foong; Erik Michelfelder; Douglas Potolka; Brian Bucher; Brad Warner; Mark Grady; Ken Azarow; Scott E Fletcher; Shelby Kutty; Jeff Delaney; Timothy Crombleholme; Erika Rosenzweig; Wendy Chung; Marc S Arkovitz
Journal:  J Pediatr       Date:  2013-01-30       Impact factor: 4.406

6.  Epidemiologic characteristics of congenital diaphragmatic hernia among 2.5 million California births, 1989-1997.

Authors:  Wei Yang; Suzan L Carmichael; John A Harris; Gary M Shaw
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-03

7.  The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia.

Authors:  Peter W Dillon; Robert E Cilley; David Mauger; Christopher Zachary; Andreas Meier
Journal:  J Pediatr Surg       Date:  2004-03       Impact factor: 2.545
  7 in total
  10 in total

Review 1.  Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates.

Authors:  Binoy Shivanna; Sharada Gowda; Stephen E Welty; Keith J Barrington; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2019-10-01

2.  Trends in use of prostacyclin analogs for management of CDH-associated pulmonary hypertension.

Authors:  Akila B Ramaraj; Samuel E Rice-Townsend; Carrie L Foster; Delphine Yung; Emma O Jackson; Ashley H Ebanks; Rebecca A Stark
Journal:  Pediatr Surg Int       Date:  2022-07-16       Impact factor: 2.003

Review 3.  Management of pulmonary hypertension in infants with congenital diaphragmatic hernia.

Authors:  J Gien; J P Kinsella
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

Review 4.  Persistent Challenges in Pediatric Pulmonary Hypertension.

Authors:  Rachel K Hopper; Steven H Abman; D Dunbar Ivy
Journal:  Chest       Date:  2016-01-22       Impact factor: 9.410

Review 5.  Early diagnosis and targeted approaches to pulmonary vascular disease in bronchopulmonary dysplasia.

Authors:  Catheline Hocq; Laetitia Vanhoutte; Axelle Guilloteau; Anna Claudia Massolo; Bénédicte Van Grambezen; Kate Carkeek; Fiammetta Piersigilli; Olivier Danhaive
Journal:  Pediatr Res       Date:  2021-03-05       Impact factor: 3.756

6.  Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.

Authors:  T J Kulik; J E Lock
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

7.  Treprostinil for persistent pulmonary hypertension of the newborn, with early onset sepsis in preterm infant: 2 Case reports.

Authors:  Bo Young Park; Sung-Hoon Chung
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 8.  Emerging antenatal therapies for congenital diaphragmatic hernia-induced pulmonary hypertension in preclinical models.

Authors:  Kathleen Marulanda; Nick D Tsihlis; Sean E McLean; Melina R Kibbe
Journal:  Pediatr Res       Date:  2020-10-10       Impact factor: 3.756

Review 9.  Congenital diaphragmatic hernia: a narrative review of controversies in neonatal management.

Authors:  Michelle J Yang; Katie W Russell; Bradley A Yoder; Stephen J Fenton
Journal:  Transl Pediatr       Date:  2021-05

10.  Changes in vasoactive pathways in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapy.

Authors:  Daphne S Mous; Marjon J Buscop-van Kempen; Rene M H Wijnen; Dick Tibboel; Robbert J Rottier
Journal:  Respir Res       Date:  2017-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.